Objectives

After participating in this educational activity, attendees should be able to:

1|Develop familiarity with anti-amyloid therapies and patient selection criteria
2|Identify amyloid-related imaging abnormalities (ARIA), associated risk factors, and management strategies
3|Recognize cerebrovascular contraindications to anti-amyloid therapy

 

 Leila Parand, MD
Neurology, Neurobehavior Specialist
UCLA Memory Clinic
David Geffen School of Medicine
Faculty name UCLA Memory Clinic
 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Leila Parand, MDSpeakerAdvisory Panel for Eli Lilly, Advisory Panel for Esai/Biogen, Speaker for PeerView No
Session date: 
10/07/2026 - 9:00am to 10:00am EDT
Location: 
Zoom
759 Chestnut Street
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.